Press Releases

GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx digital pill ID-Cap™ System. Standley’s onboarding aligns with recent etectRx partnerships with other digital health providers working toward providing solutions

GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. The collaboration is the first of its kind to

GAINESVILLE, Fla. (October 7, 2020) – etectRx, Inc. recently announced that the United States Patent and Trademark Office has issued U.S. Patent 10,765,360 for an “Electronic medication compliance monitoring system and associated methods.” The patent supports the company’s existing intellectual property for its digital pill platform technology and methods for recording and tracking a patient’s adherence

ID-Cap™ System Will Allow Cliniciansto Remotely Track Ingestion Events and Provide Feedback to Patients GAINESVILLE, Fla. (September 10, 2020) – Digital health company etectRx™, Inc. (etectRx™), today announced that its FDA-cleared ingestible event marker, the ID-Cap™ System, will be utilized in a clinical study of 60 patients to develop programs aimed to improve medication adherence

Pharma Executive Brought in to Drive Digital Pill Use Cases GAINESVILLE, Fla. (August 20, 2020) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of pharma veteran Valerie Sullivan as its next president and CEO. In late 2019, the company received FDA clearance for its novel ingestible event marker, the ID-Cap™ System. etectRx is in dialogue with pharma companies to help drive commercialization for its novel technology. Sullivan, who

Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. (January 12, 2020) – etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication. This collaborative

ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company, today announced U.S. Food and Drug Administration (FDA) clearance of its breakthrough patented ingestible event marker, the ID-Cap® System. The ID-Cap System is the first and only ingestible event marker

GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance Monitoring System and Associated Methods.” The patent covers an ingestible electronic system and methods for recording and tracking a patient’s adherence to

Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to further develop the manufacturing and assembly processes for ID-Capsules and the ID-Cap™ System. In addition, the two companies will work collaboratively to explore markets for etectRx’s proprietary technology and expand

Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March 4, 2019) – etectRx™, a privately held digital health company, is pleased to announce that its ID-Cap™ System, featuring state-of-the-art ingestion event monitoring technology, has been selected for a new